BackExscientia Plc Overview

Exscientia Plc EBIT

Latest ebit for EXAI: $-150M, below the Healthcare sector average of $23B.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

-$51.90M
41.84% YoY

As of Sep 30, 2024

Annual EBIT (TTM)

-$151.84M
18.41% YoY

Trailing 12 months ending Sep 30, 2024

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Exscientia Plc (EXAI) FAQ

Exscientia Plc (EXAI) currently reports a EBIT of $-150M as of September 2024. That compares with $-190M in the prior-year period — up 18.4% year over year. That is below the Healthcare sector average of $23B. Use the charts on this page to explore Exscientia Plc's EBIT history and peer comparisons.

Exscientia Plc's EBIT increased from $-190M to $-150M — a 18.4% year-over-year increase (period ending September 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Exscientia Plc's EBIT of $-150M is lower than the Healthcare sector average of $23B. That is roughly 100.7% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Exscientia Plc reported $-150M in EBIT as of September 2024. That compares with $-190M in the prior-year period — up 18.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $-150M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $23B. From there, open related valuation or income-statement pages for Exscientia Plc, and consider following EXAI for alerts when major investors trade the stock.